STOCK TITAN
  1. Home
  2. ANABV

ANAPTYSBIO (ANABV) Stock Price, News & Analysis

ANABV

Company Description

For FY2025, ANAPTYSBIO reported revenue of $234.6M with net income of -$13.2M and diluted earnings per share of $-0.46. The company operates at a net profit margin of -5.6%.

This page collects what Stock Titan holds for ANABV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

ANABV Rankings

Revenue
$234.6M
#2,384
Piotroski F-Score
5/9
#1,618

Latest News

View All

No recent news available for ANABV.

SEC Filings

View All

[144] Morgan Stanley (ANAB) plans 35,000-share sale; multiple insider dispositions listed

[144] ANAB (NASDAQ) affiliate reports 20,000-share exercise; multiple sales May–June 2026

[144] ANAB (ANAB) insider files Form 144 to sell 20,000 shares via option exercise

[144] ANAB (NASDAQ: ANAB) Form 144 shows Dennis Mulroy selling multiple lots

[144] ANAB (NASDAQ: ANAB) director reports multiple stock-option sales, dates listed

ANAPTYSBIO has filed 5 recent SEC filings, including 5 Form 144. The most recent filing was submitted on June 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ANABV SEC filings →

Financial Highlights

View Full Financials

ANAPTYSBIO generated $234.6M in revenue in FY2025, operating income reached $47.9M (20.4% operating margin), and net income was -$13.2M, reflecting a -5.6% net profit margin. Diluted earnings per share stood at $-0.46. The company generated $19.7M in operating cash flow. With a current ratio of 9.07, the balance sheet reflects a strong liquidity position.

$234.6M
Revenue (FY2025)
-$13.2M
Net Income (FY2025)
$-0.46
Diluted EPS (FY2025)
$19.7M
Operating Cash Flow
-5.6%
Net Profit Margin
20.4%
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the revenue of ANAPTYSBIO (ANABV) stock?

The FY2025 revenue of ANAPTYSBIO (ANABV) is $234.6M, from its most recent completed fiscal year.

What is the net income of ANAPTYSBIO (ANABV)?

The FY2025 net income of ANAPTYSBIO (ANABV) is -$13.2M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of ANAPTYSBIO (ANABV)?

The diluted earnings per share (EPS) of ANAPTYSBIO (ANABV) is $-0.46 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of ANAPTYSBIO (ANABV)?

The operating cash flow of ANAPTYSBIO (ANABV) is $19.7M. Learn about cash flow.

What is the profit margin of ANAPTYSBIO (ANABV)?

The net profit margin of ANAPTYSBIO (ANABV) is -5.6%. Learn about profit margins.

What is the operating margin of ANAPTYSBIO (ANABV)?

The operating profit margin of ANAPTYSBIO (ANABV) is 20.4%. Learn about operating margins.

What is the current ratio of ANAPTYSBIO (ANABV)?

The current ratio of ANAPTYSBIO (ANABV) is 9.07, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of ANAPTYSBIO (ANABV)?

The operating income of ANAPTYSBIO (ANABV) is $47.9M. Learn about operating income.